Vrpx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vrpx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vrpx Today - Breaking & Trending Today

Red Pine Exploration (CVE:RPX) Shares Up 18.8%

Red Pine Exploration Inc. (CVE:RPX – Get Free Report)’s share price shot up 18.8% during mid-day trading on Thursday . The company traded as high as C$0.10 and last traded at C$0.10. 489,200 shares changed hands during trading, an increase of 80% from the average session volume of 271,998 shares. The stock had previously closed […] ....

Red Pine Exploration Inc , Red Pine Exploration Company Profile , Vencan Gold Corporation , Red Pine Exploration , Get Free Report , Pine Exploration Inc , Wawa Gold Project , Red Pine Exploration Daily , Cve Rpx , Basic Material ,

Virpax Pharmaceuticals Stock to Reverse Split on Friday, March 1st (NASDAQ:VRPX)

Shares of Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Free Report) are going to reverse split before the market opens on Friday, March 1st. The 1-10 reverse split was announced on Friday, March 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 1st. Virpax Pharmaceuticals Price Performance Shares […] ....

Virpax Pharmaceuticals Company Profile , Virpax Pharmaceuticals Price Performance , Citigroup Inc , News Ratings For Virpax Pharmaceuticals Daily , Virpax Pharmaceuticals Inc , Vanguard Group Inc , Virpax Pharmaceuticals , Renaissance Technologies , Free Report , Vanguard Group , Get Free Report , Virpax Pharmaceuticals Daily , Nasdaq Vrpx , Stock Split ,

Financial Survey: Virpax Pharmaceuticals (NASDAQ:VRPX) and Verve Therapeutics (NASDAQ:VERV)

Virpax Pharmaceuticals (NASDAQ:VRPX – Get Free Report) and Verve Therapeutics (NASDAQ:VERV – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Volatility & Risk Virpax Pharmaceuticals has a […] ....

United States , United Kingdom , Broad Institute , Fellows Of Harvard College , Virpax Pharmaceuticals Inc , Beam Therapeutics Inc , Virpax Pharmaceuticals , Verve Therapeutics Inc , Endcadia Inc , News Ratings For Virpax Pharmaceuticals Daily , Acuitas Therapeutics Inc , Get Free Report , Verve Therapeutics , Given Verve Therapeutic , Verve Therapeutic , Acuitas Therapeutics , Virpax Pharmaceuticals Daily , Nasdaq Vrpx , Stock Comparison , Stock Analysis ,

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 51,500 shares, a decrease of 44.1% from the December 31st total of 92,100 shares. Currently, 0.6% of the company’s stock are sold short. Based on an […] ....

Vanguard Group Inc , Citigroup Inc , Virpax Pharmaceuticals , Renaissance Technologies , Virpax Pharmaceuticals Price Performance , Virpax Pharmaceuticals Company Profile , News Ratings For Virpax Pharmaceuticals Daily , Virpax Pharmaceuticals Inc , Hedge Funds Weigh In On Virpax Pharmaceuticals , Get Free Report , Virpax Pharmaceuticals Daily , Nasdaq Vrpx ,

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 92,100 shares, an increase of 479.2% from the December 15th total of 15,900 shares. Based on an average trading volume of 270,600 shares, the days-to-cover ratio […] ....

Renaissance Technologies , Virpax Pharmaceuticals , Virpax Pharmaceuticals Trading Down , Virpax Pharmaceuticals Inc , Institutional Trading Of Virpax Pharmaceuticals , Virpax Pharmaceuticals Company Profile , Vanguard Group Inc , Citigroup Inc , News Ratings For Virpax Pharmaceuticals Daily , Get Free Report , Pharmaceuticals Trading Down , Vanguard Group , Virpax Pharmaceuticals Daily , Nasdaq Vrpx ,